Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.57 |
| ▸ | USP2 | O75604 | 1/20 | 0.57 |
| ▸ | HTT | P42858 | 1/20 | 0.57 |
| ▸ | RECQL | P46063 | 1/20 | 0.57 |
| ▸ | MYC | P01106 | 10/20 | 0.47 |
| ▸ | IDO1 | P14902 | 2/20 | 0.47 |
| ▸ | MIF | P14174 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | MAX | P61244 | 5/20 | 0.43 |
| ▸ | GSTM2 | P28161 | 2/20 | 0.43 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25401535 | 1.00 | MEN1 (0.57) | MEN1KMT2AUSP2HTTRECQL | |
| Hydrochloric Acid SCHEMBL25405669 | 0.99 | MEN1 (0.56) | MEN1KMT2AUSP2HTTRECQL | |
| Hydrochloric Acid SCHEMBL25405658 | 0.99 | MEN1 (0.56) | MEN1KMT2AUSP2HTTRECQL | |
| SCHEMBL26269621 | 0.91 | IDO1 (0.48) | MEN1KMT2AUSP2HTTRECQL | |
| SCHEMBL25435033 | 0.88 | MEN1 (0.53) | MEN1KMT2AUSP2HTTRECQL | |
| SCHEMBL25435035 | 0.88 | MEN1 (0.53) | MEN1KMT2AUSP2HTTRECQL | |
| SCHEMBL26269121 | 0.85 | MEN1 (0.51) | MEN1KMT2AUSP2HTTRECQL | |
| SCHEMBL26268722 | 0.85 | MEN1 (0.52) | MEN1KMT2AUSP2HTTRECQL | |
| SCHEMBL26268792 | 0.83 | MEN1 (0.57) | MEN1KMT2AUSP2HTTRECQL | |
| SCHEMBL11036403 | 0.83 | MYC (0.50) | MEN1KMT2AUSP2HTTRECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230270889-A1 | Fluorescently-Traceable Amino Acid Derivative And Preparation Methods And Use Thereof | Capital Medical University (CN) | 2023-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230270889-A1 | Fluorescently-Traceable Amino Acid Derivative And Preparation Methods And Use Thereof | SLC7A5, BCAT2, BCAT1 | MEN1 4025/4885KMT2A 3420/4885USP2 2878/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.